EXHIBIT 99.1
                                                                    ------------

     CHATTEM NAMES ROBERT E. BOSWORTH PRESIDENT AND CHIEF OPERATING OFFICER

         - BOSWORTH REMAINS A DIRECTOR OF THE COMPANY; TAYLOR STEPS DOWN

CHATTANOOGA, Tenn. - (BUSINESS WIRE) - August 24, 2005 - Chattem, Inc.
(NASDAQ:CHTT), a leading marketer and manufacturer of branded OTC healthcare
products, today announced the appointment of Robert E. Bosworth as President and
Chief Operating Officer, effective September 19, 2005. Mr. Bosworth, who will
report to Zan Guerry, Chattem's Chairman and Chief Executive Officer, will focus
on the operational and administrative functions of the Company, as well as the
Company's international business. He replaces A. Alexander Taylor II, who has
resigned from Chattem, and its board, to pursue other business opportunities.
Mr. Bosworth will remain a member of the Company's board of directors, where he
has served for the last 19 years.

Mr. Bosworth, age 58, was formerly an employee of Chattem, having served for 18
years, most recently as Executive Vice President and Chief Financial Officer
overseeing operational and administrative functions from 1990 to 1998. "I am
very excited to return to Chattem in this new role and look forward to
capitalizing on the strength of the existing management team and the Company's
portfolio of superior branded products," stated Mr. Bosworth. "I look forward to
working closely with Zan in building shareholder value through the continued
implementation of plans that he and his team have developed."

"The Board and I are very pleased to have Bob rejoin our leadership team, where
we will benefit immensely from his in-depth knowledge of the Company, strong
experience in operations management and proven record of success," said Zan
Guerry. "More than ever, Chattem's growth opportunities abound as a result of
our strong product innovation pipeline. Bob's leadership will help ensure we
fully realize the growth opportunities before us."

Mr. Guerry added, "Alec has made important contributions to Chattem's success
during his nearly eight years as President and Chief Operating Officer and
twelve years as a director. In particular, his work on the successful resolution
of our Dexatrim-related litigation and his enhancement of Chattem's reputation
in the investment community have been outstanding. The Board and I thank Alec
for his hard work and dedication to Chattem and wish him well in his future
business pursuits."

Mr. Bosworth is currently Vice President of Corporate Finance for Livingston
Company, a merchant banking and wealth management company specializing in
providing expansion capital to small and middle market companies. Before joining
Livingston Company in 2001, he served as a consultant to and member of the
Boards of Directors of several public and private companies in diverse
industries from 1998 to 2001. In addition to serving on Chattem's Board of
Directors, Mr. Bosworth is a director of Covenant Transport, Inc. (Nasdaq:
CVTI). He earned his Bachelor of Arts degree in Economics from Amherst College
in 1974 and a Masters in Business Administration from the University of North
Carolina at Chapel Hill in 1976.



Chattem, Inc. is a leading marketer and manufacturer of a broad portfolio of
branded OTC healthcare products, toiletries and dietary supplements. The
Company's products target niche market segments and are among the market leaders
in their respective categories across food, drug and mass merchandisers. The
Company's portfolio of products includes well-recognized brands such as Icy
Hot(R), Gold Bond(R), Selsun Blue(R), pHisoderm(R), Garlique(R), Pamprin(R) and
BullFrog(R). Chattem conducts a portion of its global business through
subsidiaries in the United Kingdom, Ireland and Canada.

STATEMENTS IN THIS PRESS RELEASE WHICH ARE NOT HISTORICAL FACTS ARE
FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995. THESE FORWARD-LOOKING STATEMENTS INVOLVE RISKS,
UNCERTAINTIES AND ASSUMPTIONS THAT COULD CAUSE ACTUAL OUTCOMES AND RESULTS TO
DIFFER MATERIALLY FROM THOSE EXPRESSED OR PROJECTED.

For more information, contact:

Rick Moss, Chief Financial Officer, 423-822-3278
or
Catherine Baker, Manager of Investor Relations, 423-822-3209